paclitaxel has been researched along with Carcinoma, Bronchial in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gajbhiye, KR; Pandey, V; Soni, V | 1 |
| Creaven, P; Hicks, W; Levine, E; Loewen, G; Meropol, N; Pendyala, L; Perez, R; Raghavan, D | 1 |
| Diergarten, K; Faoro, C; Görg, C; Havemann, K; Merte, H; Pfab, R; Wolf, M | 1 |
| Gatzemeier, U | 1 |
| Manegold, C | 1 |
| Flentje, M; Willner, J | 1 |
3 review(s) available for paclitaxel and Carcinoma, Bronchial
| Article | Year |
|---|---|
[Taxol in bronchial carcinoma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Humans; Lung Neoplasms; Neoplasm Staging; Paclitaxel; Survival Rate; Treatment Outcome | 1996 |
[Docetaxel (taxotere): current status of clinical development in non-small-cell bronchial carcinoma (NSCLC)].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Lung Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome | 1998 |
[Combined radiochemotherapy of non-small-cell bronchial carcinoma with taxol].
Topics: Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose Fractionation, Radiation; Humans; Lung Neoplasms; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy Planning, Computer-Assisted | 1999 |
2 trial(s) available for paclitaxel and Carcinoma, Bronchial
| Article | Year |
|---|---|
Phase I study of paclitaxel and carboplatin: implications for trials in head and neck cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Female; Granulocyte Colony-Stimulating Factor; Half-Life; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel | 1995 |
[Paclitaxel and simultaneous radiotherapy in stage-III non-small-cell bronchial carcinoma].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pilot Projects; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome | 1996 |
1 other study(ies) available for paclitaxel and Carcinoma, Bronchial
| Article | Year |
|---|---|
Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Bronchogenic; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Compounding; Drug Delivery Systems; Humans; Lactoferrin; Lung; Lung Neoplasms; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Solubility; Surface Properties; Tissue Distribution | 2015 |